1. Stocks
  2. Concord Biotech Ltd.
  3. Swot
swot-logo

Concord Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Concord Biotech Ltd. has 15 Strengths, 9 Weaknesses, 1 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years - Nifty500

Relative Outperformance versus Industry over 1 Month

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Decline in Net Profit (QoQ)

Weak Momentum: Price below Short, Medium and Long Term Averages

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

Stocks Underperforming their Industry Price Change in the Quarter

FII / FPI or Institutions increasing their shareholding

MFs decreased their shareholding last quarter

Rising Delivery Percentage Compared to Prev Day

Expensive Performers (DVM)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks